The aortic valve flow rate may be a good parameter to stratify risk in patients with certain cases of aortic valve stenosis, according to researchers.
- Dobutamine echocardiography is a stress test used to determine cardiac risk
- Researchers from Mayo Clinic believe that the aortic valve flow rate may be a good parameter to stratify risk in patients with low-flow, low-gradient aortic stenosis
- The test could help doctors decide on the future course of treatment for the patient
Dobutamine Echocardiogram is a stress test that is particularly useful in patients who cannot undergo a treadmill test. Echocardiography is a test that uses sound waves that are reflected from the heart and give a video image of the structure and functioning of the heart. During the test, dobutamine is sometimes given by injection.
Dobutamine increases the heart rate and force of contraction, thereby increasing the stress on the heart. The test helps to detect abnormalities in blood flow to the heart muscle or the condition of heart valves.
Researchers Said Alsidawi and others from Mayo Clinic believe that measurement of a parameter called the aortic valve flow rate during a dobutamine echocardiogram test may be a good indicator of the risk of certain patients for a cardiac event.
The aortic valve is the valve at the junction of the left ventricle of the heart and the aorta, the main artery of the body. It ensures that blood flows in a single direction and prevents backflow of blood to the heart. Narrowing of the aortic valve is called aortic stenosis.
References:
- CALCULATING AORTIC FLOW RATE SUPERIOR TEST FOR PATIENT RISK STRATIFICATION
http://asecho.org/wordpress/wp-content/uploads/2016/06/Alsidawi-Mayo-Aortic-Flow-Rate-Release.pdf